130 related articles for article (PubMed ID: 29726398)
1. Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality.
Bozkurt S; Okay M; Haznedaroğlu İ
Turk J Haematol; 2019 Feb; 36(1):62-63. PubMed ID: 29726398
[No Abstract] [Full Text] [Related]
2. Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1;15)(q10;q26).
Akalin I; Kutlay NY; Ilhan O; Tukun A
Int J Lab Hematol; 2007 Jun; 29(3):215-20. PubMed ID: 17474900
[TBL] [Abstract][Full Text] [Related]
3. [Multicolor spectral karyotyping (SKY) and its application to the cytogenetic diagnosis of multiple myeloma].
Cigudosa JC; Calasanz MJ; García Miranda JL
Sangre (Barc); 1999 Aug; 44(4):301-4. PubMed ID: 10589283
[No Abstract] [Full Text] [Related]
4. 16q23/MAF Gene Deletion Is a Frequent Cytogenetic Abnormality in Multiple Myeloma Associated With IgH Deletion but Significantly Lower Incidence of High-Risk Translocations.
Rana S; Sreedharanunni S; Panakkal V; Singh Sachdeva MU; Varma N; Malhotra P
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e398-e401. PubMed ID: 33309247
[No Abstract] [Full Text] [Related]
5. Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents.
Mina R; Joseph NS; Gay F; Kastritis E; Petrucci MT; Kaufman JL; Montefusco V; Gavriatopoulou M; Patriarca F; Omedé P; Boise LH; Roussou M; Giuliani N; Oliva S; Offidani M; Belotti A; Jaye DL; De Paoli L; Terpos E; Lonial S; Boccadoro M; Nooka AK; Dimopoulos MA
Blood Cancer J; 2020 Apr; 10(4):40. PubMed ID: 32286263
[No Abstract] [Full Text] [Related]
6. t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.
Narita T; Inagaki A; Kobayashi T; Kuroda Y; Fukushima T; Nezu M; Fuchida S; Sakai H; Sekiguchi N; Sugiura I; Maeda Y; Takamatsu H; Tsukamoto N; Maruyama D; Kubota Y; Kojima M; Sunami K; Ono T; Ri M; Tobinai K; Iida S
Blood Cancer J; 2015 Feb; 5(2):e285. PubMed ID: 25723856
[No Abstract] [Full Text] [Related]
7. Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Avet-Loiseau H; Malard F; Campion L; Magrangeas F; Sebban C; Lioure B; Decaux O; Lamy T; Legros L; Fuzibet JG; Michallet M; Corront B; Lenain P; Hulin C; Mathiot C; Attal M; Facon T; Harousseau JL; Minvielle S; Moreau P;
Blood; 2011 Feb; 117(6):2009-11. PubMed ID: 20962323
[TBL] [Abstract][Full Text] [Related]
8. Novel constitutional translocations t(3;5)(p25;q22) and t(1;14)(p31;q21) in patients with acute leukemia.
Panani AD; Pappa V; Raptis SA
Ann Hematol; 2004 Mar; 83(3):156-9. PubMed ID: 15064864
[TBL] [Abstract][Full Text] [Related]
9. De novo complex chromosomal rearrangement of 46, XY, t (3; 16; 8) (p26; q13; q21.2) in a non-obstructive azoospermic male.
Salahshourifar I; Gilani MA; Vosough A; Tavakolzadeh T; Tahsili M; Mansori Z; Karimi H; Totonchi M; Gourabi H
J Appl Genet; 2007; 48(1):93-4. PubMed ID: 17272868
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
[TBL] [Abstract][Full Text] [Related]
11. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
[TBL] [Abstract][Full Text] [Related]
12. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
[TBL] [Abstract][Full Text] [Related]
13. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
[TBL] [Abstract][Full Text] [Related]
14. A patient with meningioma showing multiple cytogenetic abnormalities and a constitutional translocation (3;9)(q13.3;q22).
Niazi M; van Dijken PJ; al Moutaery K
Cancer Genet Cytogenet; 1998 Aug; 105(1):11-3. PubMed ID: 9689923
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization identifies inversion 16 masked by t(10;16)(q24;q22), t(7;16)(q21;q22), and t(2;16)(q37;q22) in three cases of AML-M4Eo.
Reddy KS; Wang S; Montgomery P; Grove W; Robertson LE
Cancer Genet Cytogenet; 2000 Jan; 116(2):148-52. PubMed ID: 10640147
[TBL] [Abstract][Full Text] [Related]
16. Novel translocation t(3;11)(p21;q24) in multiple myeloma characterised by FISH.
Smith A; de Lambert R; Robson L
Ann Genet; 1999; 42(4):221-4. PubMed ID: 10674162
[TBL] [Abstract][Full Text] [Related]
17. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
[TBL] [Abstract][Full Text] [Related]
18. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.
Torlakovic EE; Aamot HV; Heim S
J Pathol; 2006 Jun; 209(2):258-64. PubMed ID: 16583359
[TBL] [Abstract][Full Text] [Related]
19. Two cases of t(1;16)(p11;p11) in multiple myeloma: confirmation by chromosome painting.
Flactif M; Laï JL; Zandecki M; Bernardi F; Trillot N; Bauters F; Facon T
Cancer Genet Cytogenet; 1994 Aug; 76(1):10-4. PubMed ID: 8076342
[TBL] [Abstract][Full Text] [Related]
20. CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity.
Bataille R; Robillard N; Avet-Loiseau H; Harousseau JL; Moreau P
Haematologica; 2005 May; 90(5):706-7. PubMed ID: 15921396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
